Biocon shares in focus as Viatris-owned Mylan plans stake sale via block deal: Sources
Viatris-owned Mylan is looking to sell part of its 5.64% stake in Biocon Ltd through a block deal, according to sources. The transaction is expected to take place in the coming days and could be executed within the next seven to eight days. Mylan acquired the stake after Biocon completed its acquisition of the company’s…
